DOTA-Octreotide TFA consists of the chelating agent DOTA and Octreotide. It is utilized in cancer research through its ability to bind with radioactive elements and is also employed in the synthesis and study of radiolabeled conjugate drugs (RDC).
Molekulargewicht:
1519.66
Formel:
C67H93F3N14O19S2
TP3068
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
